Unique CMO Focus Sever Pharma Solutions specializes in controlled release systems for highly potent drugs and aseptic fill and finish, presenting a strong value proposition for pharma companies seeking CDMO partners with expertise in high-potent, niche delivery platforms and end-to-end development to commercial manufacturing.

Expansion and Leadership Recent leadership appointments including General Counsel, Vice President of Quality, VP Operations, and a new CEO indicate formalized growth plans and governance capabilities, creating opportunities to position SPS as a scalable partner for large-scale projects and global regulatory-ready operations.

Strategic Collaborations Past and ongoing partnerships, such as the Silo Pharma ketamine implant collaboration, demonstrate SPS’ readiness for co-development and specialty implants, suggesting opportunities to expand into additional high-potency and solubility enhancement programs with biotech and pharma firms.

Geographic Footprint Dual manufacturing facilities in Malmö and Putnam combined with a global HR and operations focus signal capacity to support regional and cross-border programs, enabling sales outreach to multinational companies seeking nearshore and offshore CDMO alternatives.

Technical Advantage Core competencies in polymer-based sustained-release dosage forms, hot melt extrusion, and aseptic fill and finish for high potent drugs position SPS to win programs requiring complex formulation development, regulatory readiness, and scalable manufacturing for niche delivery systems.